Majority in UK want new tax on makers of ultra-processed and junk food
Exclusive: Poll findings prompt calls for ministers to impose sugar tax-style levy on companies to combat obesity
Novo Nordisk cuts profit outlook after weaker sales of weight-loss drug Wegovy
Danish company, which also makes Ozempic, faces increasing competition from US rival Eli Lilly
Are ultra-processed foods always harmful?
Letters: People buy ultra-processed foods because they can’t afford anything else, writes Laurence N Mann; plus letters from Helen Grist and Niklas Grundstrom
July 2024
Ozempic or Wegovy can be a godsend, but their non-medical use is alarming
Devi Sridhar
Weight-loss jab gets green light to be used to prevent heart attacks in UK
Why preventing long-term sickness in the UK is an economic necessity
Children’s sugar consumption halved since tax announcement, study finds
Much of NHS in England ‘does not take obesity seriously enough’
Weight-loss jabs may be linked to condition that can cause blindness, study finds
June 2024
‘Skinny jabs’: weight-loss drugs set for new boom as generic versions emerge
New York’s Fat Beach Day gives plus-size people a space to be themselves
Some takeaway meals contain more calories than daily limit, GB study finds
Weight loss drug could ease sleep apnoea in people with obesity, study says
UK children shorter, fatter and sicker amid poor diet and poverty, report finds
Alarming lack of access to green space fuelling UK child obesity crisis, doctors warn
Top doctor warns against using anti-obesity drugs to get ‘beach body ready’
Tobacco, alcohol, processed foods and fossil fuels ‘kill 2.7m a year in Europe’
Mounjaro is second obesity drug to be approved for use in England
Cancer rates among under-50s in UK have risen 24% since 1995, figures show
Extend success of UK sugar tax to cakes, biscuits and chocolate, experts urge
